Joanne Hackett
Corporate Officer/Principal chez IQVIA HOLDINGS INC.
Profil
Joanne M.
Hackett is currently the Head of Genomic & Precision Medicine at IQVIA Holdings, Inc. She previously held positions as the Director of Commercial Development at UCL Partners Ltd.
from 2013 to 2016, the Chief Commercial Officer at Genomics England Ltd.
from 2017 to 2020, and the Chief Executive & Commercial Officer at Precision Medicine Catapult from 2016 to 2017.
She also served as an Independent Director at AgeX Therapeutics, Inc. in 2021 and 2022.
Dr. Hackett obtained a doctorate degree from the University of New Brunswick.
Postes actifs de Joanne Hackett
| Sociétés | Poste | Début |
|---|---|---|
| IQVIA HOLDINGS INC. | Corporate Officer/Principal | - |
Anciens postes connus de Joanne Hackett
| Sociétés | Poste | Fin |
|---|---|---|
Genomics England Ltd.
 Genomics England Ltd. Miscellaneous Commercial ServicesCommercial Services Genomics England Ltd. runs and delivers 100,000 genomes project. Its flagship project sequences 100,000 genomes from NHS patients with a rare disease and their families, and patients with cancer. The company was founded by Jeremy Hunt on July 5, 2013 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | 01/01/2020 |
Precision Medicine Catapult
 Precision Medicine Catapult BiotechnologyHealth Technology Precision Medicine Catapult is a British company that engages in the research and development of biotechnology. The private company is based in Oxford, UK. | Chief Executive Officer | 01/01/2017 |
UCL Partners Ltd.
 UCL Partners Ltd. Medical/Nursing ServicesHealth Services UCL Partners Ltd. is a British company that supports health and care improvements. The private company is based in London, UK. The company was founded in 2009. Charlie Davie has been the CEO of the company since 2009. | Corporate Officer/Principal | 01/01/2016 |
| Cambridge University Health Partners | Chief Operating Officer | - |
| AGEX THERAPEUTICS, INC. | Chief Executive Officer | - |
Formation de Joanne Hackett
| University of New Brunswick | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| IQVIA HOLDINGS INC. | Health Services |
| Entreprise privées | 5 |
|---|---|
UCL Partners Ltd.
UCL Partners Ltd. Medical/Nursing ServicesHealth Services UCL Partners Ltd. is a British company that supports health and care improvements. The private company is based in London, UK. The company was founded in 2009. Charlie Davie has been the CEO of the company since 2009. | Health Services |
Genomics England Ltd.
Genomics England Ltd. Miscellaneous Commercial ServicesCommercial Services Genomics England Ltd. runs and delivers 100,000 genomes project. Its flagship project sequences 100,000 genomes from NHS patients with a rare disease and their families, and patients with cancer. The company was founded by Jeremy Hunt on July 5, 2013 and is headquartered in London, the United Kingdom. | Commercial Services |
| Cambridge University Health Partners | |
Precision Medicine Catapult
Precision Medicine Catapult BiotechnologyHealth Technology Precision Medicine Catapult is a British company that engages in the research and development of biotechnology. The private company is based in Oxford, UK. | Health Technology |
AgeX Therapeutics, Inc.
 AgeX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology AgeX Therapeutics, Inc. operates as a biotechnology company, which engages in the development and commercialization of novel therapeutics targeting human aging and degenerative diseases. Its product pipeline includes AGEX-VASC1, AGEX-BAT1, and AGEX-iTR1547. The company was founded by Michael D. West in 2017 and is headquartered in Alameda, CA. | Health Technology |
